论文信息 - Comparison between Dasatinib-Blinatumomab Vs Ponatinib-Blinatumomab Chemo-Free Strategy for Newly Diagnosed Ph+ Acute Lymphoblastic Leukemia Patients. Preliminary Results of the Gimema ALLL2820 Trial - 字舞流文

Comparison between Dasatinib-Blinatumomab Vs Ponatinib-Blinatumomab Chemo-Free Strategy for Newly Diagnosed Ph+ Acute Lymphoblastic Leukemia Patients. Preliminary Results of the Gimema ALLL2820 Trial

S. Chiaretti | L. Elia | P. Fazi | D. Vallisa | A. Piciocchi | B. Martino | M. Messina | E. Borlenghi | V. Mancini | S. Imbergamo | S. Soddu | M. Matarazzo | Mario Luppi | Robin Foà | Calogero Vetro | A. Rambaldi | Giuseppe Visani | Matteo Leoncin | Mariangela Di Trani | Simona Sica | Carmine Selleri